A phospholipid–apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

Juliette Morgan, Kathleen Wannemuehler, Kieren A. Marr et al. · Medical Mycology · 2005 · 409 citations

Life Sciences, Infectious Diseases, Microbiology +14

The Water and Nonelectrolyte Permeability Induced in Thin Lipid Membranes by the Polyene Antibiotics Nystatin and Amphotericin B

Ronald W. Holz, Alan Finkelstein · The Journal of General Physiology · 1970 · 316 citations · Full text

Natural Sciences, Biophysics, Pharmacology +17

Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial

Bart Rijnders, Jan J. Cornelissen, Lennert Slobbe et al. · Clinical Infectious Diseases · 2008 · 281 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

A S Janoff, Lawrence T. Boni, Mircea Popescu et al. · Proceedings of the National Academy of Sciences · 1988 · 223 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents

Richard T. Proffitt, A. Satorius, S.-M. Chiang et al. · Journal of Antimicrobial Chemotherapy · 1991 · 202 citations

Pharmacy, Pharmacology, Toxicology +15